Group One Trading’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-500
| Closed | -$14K | – | 9088 |
|
|
2021
Q4 | $14K | Hold |
500
| – | – | ﹤0.01% | 7205 |
|
|
2021
Q3 | $14K | Sell |
500
-10,600
| -95% | -$262K | ﹤0.01% | 7371 |
|
|
2021
Q2 | $190K | Sell |
11,100
-24,400
| -69% | -$457K | ﹤0.01% | 5301 |
|
|
2021
Q1 | $741K | Sell |
35,500
-2,900
| -8% | -$66.9K | ﹤0.01% | 3578 |
|
|
2020
Q4 | $879K | Buy |
38,400
+20,000
| +109% | +$381K | ﹤0.01% | 2765 |
|
|
2020
Q3 | $300K | Sell |
18,400
-7,000
| -28% | -$127K | ﹤0.01% | 3320 |
|
|
2020
Q2 | $344K | Buy |
25,400
+13,200
| +108% | +$154K | ﹤0.01% | 2927 |
|
|
2020
Q1 | $145K | Sell |
12,200
-2,800
| -19% | -$62.1K | ﹤0.01% | 3004 |
|
|
2019
Q4 | $374K | Buy |
+15,000
| New | +$304K | ﹤0.01% | 2670 |
|
|
2019
Q3 | – | Sell |
-36,300
| Closed | -$826K | – | 5736 |
|
|
2019
Q2 | $826K | Buy |
36,300
+1,400
| +4% | +$37.8K | 0.01% | 1726 |
|
|
2019
Q1 | $1.12M | Buy |
+34,900
| New | +$1.08M | 0.01% | 1325 |
|
|
2018
Q4 | – | Sell |
-17,800
| Closed | -$512K | – | 5628 |
|
|
2018
Q3 | $512K | Sell |
17,800
-14,200
| -44% | -$427K | ﹤0.01% | 2262 |
|
|
2018
Q2 | $1.2M | Buy |
32,000
+29,200
| +1,043% | +$1.15M | 0.01% | 1540 |
|
|
2018
Q1 | $110K | Buy |
2,800
+600
| +27% | +$21.9K | ﹤0.01% | 3190 |
|
|
2017
Q4 | $71K | Buy |
2,200
+1,100
| +100% | +$33K | ﹤0.01% | 3547 |
|
|
2017
Q3 | $34K | Sell |
1,100
-10,400
| -90% | -$308K | ﹤0.01% | 3828 |
|
|
2017
Q2 | $321K | Buy |
+11,500
| New | +$260K | ﹤0.01% | 2301 |
|
Group One Trading's XENT Position: Q2 2022 in Review
Group One Trading sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 14,086 shares — an estimated $395K sold.
Group One Trading first reported a position in XENT in Q3 2016 and held it in 13 quarters. The position peaked at $802K in Q3 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Group One Trading reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Group One Trading sold 14,086 Intersect ENT, Inc shares in Q2 2022, an estimated $395K.
- Group One Trading first reported a position in Intersect ENT, Inc in Q3 2016 and held it in 13 quarters.
- Group One Trading's Intersect ENT, Inc position peaked at $802K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.